ask="34.47"
ask_size="100"
average_daily_volume="57516"
bid="N/A"
bid_size="N/A"
book_value="1.19"
change="-0.14"
change_from_200_day_moving_average="-1.12"
change_from_50_day_moving_average="-0.27"
change_from_52_week_high="-3.46"
change_From_52_week_low="0.39"
change_in_percent="-4.44%"
close="3.01"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-3.90"
ebitda="-15.74M"
eps_estimate_current_year="-3.71"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-2.81"
ex_dividend_date="N/A"
float_shares="5652000"
high="3.16"
high_52_weeks="6.47"
last_trade_date="2/1/2017"
last_trade_price="3.01"
last_trade_size="200"
last_trade_time="4:00pm"
low="3.00"
low_52_weeks="2.62"
market_capitalization="18.95M"
moving_average_200_day="4.13"
moving_average_50_day="3.28"
name="MABVAX THERAPEUTICS"
notes="N/A"
one_year_target_price="18.00"
open="3.09"
pe_ratio="N/A"
peg_ratio="-0.01"
percent_change_from_200_day_moving_average="-27.05%"
percent_change_from_50_day_moving_average="-8.33%"
percent_change_from_52_week_high="-53.51%"
percent_change_from_52_week_low="+14.89%"
previous_close="3.15"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.64"
price_per_sales="21.90"
revenue="905615.00"
shares_outstanding="6296000"
short_ratio="7.95"
stock_exchange="NCM"
symbol="MBVX"
volume="42377"
weeks_range_52="2.62 - 6.47"
